Therapeutic Areas

European Fertility Week 2025: IBSA renews its commitment to reproductive medicine training

The European Fertility Week (EFW2025) begins today. Held annually during the first week of November, this week is dedicated to raising awareness about infertility and the challenges patients face on their journey to parenthood.

The initiative aims to promote dialogue, provide training pathways and all-round care, highlighting not only the medical process but also the personal and social impacts that couples face, to encourage informed and conscious decisions about their reproductive health.

IBSA'S MEDICAL AND SCIENTIFIC TRAINING IN FERTILITY

In this scenario, IBSA confirms its commitment, with the person at the centre and – consequently – clinicians, who are the key figures in supporting couples throughout the complex treatment pathway.

IBSA organises various medical training activities that aim to provide clinicians with practical tools, contributing to the cultural and scientific growth of the community.

The activities promoted by IBSA are:

  • Educational symposia at major international conferences, such as the one organised in July at ESHRE;
  • Masterclasses for clinicians;
  • Collaborations with scientific societies;
  • The IBSA Educational Program platform, a true “digital library” of all the materials produced by IBSA in recent years.
European Fertility Week 2025

 

Particular attention is paid to young clinicians, as investing in their training today means contributing to build the skills that will guide reproductive medicine tomorrow. This is demonstrated by the Masterclass in ART (Assisted Reproductive Technology), now in its third edition, which has brought together young clinicians specialising in reproductive medicine with European Key Opinion Leaders, fostering direct and enriching dialogue between established experience and new perspectives.

MEETING THE NEEDS OF THE SCIENTIFIC COMMUNITY

European Fertility Week 2025

Each new IBSA training project is developed to meet the specific needs of the scientific community in the therapeutic area concerned. This was the case with the first edition of the Masterclass in Modern Diagnosis of Adenomyosis in ART: The Clinical and Imaging Approach, which took place in Naples (Italy) at the Federico II University. The programme responded to a concrete need among clinicians, providing participants with innovative tools to manage patients with adenomyosis (a benign condition of the uterus in which the tissue lining the uterine cavity, or endometrium, penetrates the muscle wall, or myometrium) who are undergoing or are about to undergo medically assisted reproduction (MAR). The interactive lessons included pathophysiology and clinical management, sonography, hysteroscopy and practical simulations.

Fertility Week represents an important opportunity, but not the only one, to reaffirm that fertility is an area that requires continuous scientific updating. IBSA confirms its role as a consolidated partner of the community involved in this therapeutic area with an approach that combines training and constant dialogue with healthcare professionals: knowledge, collaboration and interaction between experts to make a tangible contribution to innovation for the benefit of patients.